Association between NAT2, CYP1A1, and CYP1A2 genotypes, heterocyclic aromatic amines, and prostate cancer risk: a case control study in Japan

BACKGROUND: Heterocyclic aromatic amines (HAAs) may confer prostate cancer risk; however, the evidence is inconclusive and the activity of HAA-metabolizing enzymes is modulated by gene variants. The purpose of our study was to determine whether there was evidence of an association between HAA intake...

Descripción completa

Detalles Bibliográficos
Autores principales: Koda, Masahide, Iwasaki, Motoki, Yamano, Yuko, Lu, Xi, Katoh, Takahiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5664586/
https://www.ncbi.nlm.nih.gov/pubmed/29165164
http://dx.doi.org/10.1186/s12199-017-0681-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5664586/
https://www.ncbi.nlm.nih.gov/pubmed/29165164
http://dx.doi.org/10.1186/s12199-017-0681-0

Ejemplares similares